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Abstract
Background: Accumulating evidence has demonstrated that over-expression of Neuroglobin (Ngb) is
neuroprotective against hypoxic/ischemic brain injuries. In this study we tested the neuroprotective effects of Ngb
over-expression against traumatic brain injury (TBI) in mice.
Results: Both Ngb over-expression transgenic (Ngb-Tg) and wild-type (WT) control mice were subjected to TBI
induced by a controlled cortical impact (CCI) device. TBI significantly increased Ngb expression in the brains of both
WT and Ngb-Tg mice, but Ngb-Tg mice had significantly higher Ngb protein levels at the pre-injury baseline and
post-TBI. Production of oxidative tissue damage biomarker 3NT in the brain was significantly reduced in Ngb-Tg
mice compared to WT controls at 6 hours after TBI. The traumatic brain lesion volume was significantly reduced in
Ngb Tg mice compared to WT mice at 3 weeks after TBI; however, there were no significant differences in the
recovery of sensorimotor and spatial memory functional deficits between Ngb-Tg and WT control mice for up to 3
weeks after TBI.
Conclusion: Ngb over-expression reduced traumatic lesion volume, which might partially be achieved by
decreasing oxidative stress.
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Background
Neuroglobin (Ngb) is a member of the tissue globin
family with a high affinity for oxygen, and it is widely
expressed in the neurons of vertebrate central and per-
ipheral nervous systems, retina, and endocrine tissues
[1-3]. Accumulating evidence from our lab and others
has demonstrated that Ngb over-expression is neuro-
protective against hypoxic/ischemic brain injuries in
cell cultures and stroke animal models, as well as in
beta-amyloid-induced neurotoxicity in vitro and Alz-
heimer’s phenotype in mice [4-7]. Although the under-
lying neuroprotective mechanisms remain largely
unknown, experimental studies have suggested that
Ngb may act as an oxygen sensor in regulating the
signaling pathway, attenuating oxidative stress and pre-
serving mitochondrial function [4,8-11]. Traumatic
brain injury is one of the major acute neurological dis-
orders, but the effects of Ngb over-expression on its
neurological outcomes remain uninvestigated. There-
fore, in this study we tested whether Ngb over-
expression is neuroprotective against traumatic brain
injury in mice.
Methods
All animal experiments were performed following proto-
cols approved by the Massachusetts General Hospital
Animal Care and Use Committee in compliance with
the National Institutes of Health Guide for the Care and
Use of Laboratory Animals.
Controlled cortical impact model of traumatic brain injury
The standard controlled cortical impact model of trau-
matic brain injury was performed as previously described
[12,13]. Briefly, a right craniotomy was made using a port-
able drill and 5 mm trephine over the right parieto-
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were subjected to CCI using a pneumatic cylinder with a
3-mm flat-tip impounder, velocity 6 m/s, depth of
0.6 mm, and 150 ms impact duration. Ngb-Tg mice and
WTcontrol mice in C57BL/6 background were ear-tagged
and assigned randomly into two equal-sized groups,
blinded to the investigators.
Immunohistochemistry
Immunohistochemistry was performed following the
standard method as we previously described [5]. Briefly,
at 6 h after TBI, mice were anesthetized with an over-
dose isoflurane and were transcardially perfused with
chilled (4°C) PBS (pH 7.4). Coronal sections (12 μm) on
slides were fixed in 100% cold aceton and blocked in
PBS with 3% bovine serum albumin for 1 h and incu-
bated at 4°C overnight in a PBS solution containing the
rabbit anti-Ngb antibody (1:50; Santa Cruz Biotechnology,
CA, US) in 0.3% bovine serum albumin. The sections were
then washed and incubated for 1 h with Rhodamine
(TRITC)-AffiniPure Goat Anti-Rabbit IgG (H + L)(1:200;
Jackson ImmunoResearch, PA, US). Signals in peri-
lesion cortex were examined using an Olympus micro-
scope (BX51; Olympus) equipped with rhodamine fil-
ter set.
Western blots
Western blots analysis was performed following the
standard method as we previously described [5]. Briefly,
injured brain hemisphere tissues were dissected on ice,
followed by protein extraction. Protein concentrations in
the supernatants were measured with Bradford assay
(Bio-Rad, Hercules, CA, USA). Equal amount of protein
were separated in a 4-20% Tris-glycine gel (Invitrogen)
(40 μg/lane) and then transferred onto PVDF Membranes.
The membranes were incubated with primary anti-
Ngb antibody (1:1000; Biovendor R&D, NC, USA) and
anti-β-actin antibody (1:10000; Sigma) at 4°C over-
night. Then the membranes were incubated with horse-
radish peroxidase-linked rabbit polyclonal anti-Chicken
IgY (1:2000, Abcam, MA, USA) and anti-mouse IgG
(1:10000, GE Healthcare, UK), respectively for 1 hr at
room temperature, developed by enhanced chemilu-
minescent (Pierce, Rockford, IL, USA). Densitometric
analysis was performed for quantitation with Image J
software.
Slot-immunoblotting analysis
3-nitrotyrosine (3NT) production in brain tissues after
TBI was assessed with slot-immunoblotting analysis fol-
lowed by a standard method described by others, with
minor modifications [14,15]. Briefly, at 6 h after TBI,
mice were transcardially perfused with chilled (4°C) PBS
(pH 7.4), and the brains were carefully removed and
placed in a cooled (6°C) brain matrix. A 3 mm thick slice
was cut in coronal orientation and separated in quad-
rants. The right-upper (traumatized) region was col-
lected, frozen in liquid nitrogen and stored at -80°C
until further processing. To measure 3-nitrotyrosine
(3NT) production, an aliquot of each ipsilateral brain
sample (1 μg) was diluted with 200 μl of tris-buffered sa-
line (TBS) and transferred to a protran nitrocellulose
membrane (Whatman Inc., ME, US) by a Minifold I vac-
uum slot blot apparatus (Whatman Inc., ME, US). After
the samples were loaded into the slots, they were
allowed to filter through the membrane by vacuum.
Each slot was then washed with 200 μl TBS, which was
allowed to filter through the membrane again. The
membranes were disassembled from the apparatus and
incubated in a TBS blocking solution with 5% milk for
1 h at room temperature. Then the membranes were
incubated with rabbit polyclonal anti-nitrotyrosine anti-
body (1:2000; Sigma, MA, US) at 4°C overnight. After
the primary incubation, the membranes were washed
and then incubated again with horseradish peroxidase-
linked anti-rabbit IgG (1:2000, Abcam, MA, USA) for
1 h at room temperature, developed by enhanced chemi-
luminescent (Pierce, Rockford, IL, US). Densitometric
analysis was performed for quantitation with Image J
software.
Assessments of sensorimotor functions
A 10-point neurological severity score (NSS) was used
for the assessment of posttraumatic neurological impair-
ment, as previously described [16,17]. The score consists
of 10 individual clinical parameters, including tasks on
motor function, alertness, and physiological behavior,
whereby 1 point is given for failure of one task and no
points are given for success. A maximal NSS of 10
points indicates severe neurological dysfunction, with
failure at all tasks. The NSS was assessed at 1, 3, 5, 7, 10,
14 and 21 days after TBI. All mice were trained and pre-
tested prior to injury. Vestibulomotor function was
assessed using a standard wire-grip test [18]. Mice were
placed on a metal wire (45 cm long) suspended 45 cm
above a foam pad and were allowed to traverse the wire
for 60 seconds. The latency that a mouse remained on
the wire within a 60 second interval was measured, and
wire grip scores were quantitated using a 5-point scale.
0=fell off the wire within the 30 s period, 1=held on in
some way for 30 s, 2=held on with four paws for ≥5s ,
3=held on with four paws and placed tail on wire for
≥5 s, 4=held on with four and move to the end of the
wire, 5=move to the end of the wire and go down to the
ground with four paws The tests were performed in trip-
licate, and an average value was calculated for each
mouse on each day of testing. Baseline assessment was
done the day before injury.
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The Morris Water Maze task was used to evaluate
spatial memory performance from 15 days to 21 days
after TBI as previously described [18]. Briefly, perform-
ance in the MWM was quantitated by latency to the
platform. The apparatus consisted of a white pool
(90 cm diameter, 60 cm deep) filled with water to 29 cm
depth, with several highly visible cues located on the
walls of each of the four quadrants. Water temperature
was maintained between 21°C and 25°C. A clear Plexiglass
goal platform 5 cm in diameter was positioned 0.5 cm
below the water surface approximately 15 cm from the
southwest wall. Each mouse was subjected to a series of
four trials per day. For each trial, mice were randomized
to one of four starting locations (north, south, east, or
west) and placed in the pool facing the wall. Mice were
given a maximum of 60 seconds to find the submerged
platform. If the mouse failed to reach the platform by
60 seconds, it was placed on the platform by the ex-
perimenter and allowed to remain there for 15 sec-
onds. Mice were placed in a warming chamber for at
least 4 minutes between trials. To control for possible
differences in visual acuity or sensorimotor function
between groups, two trials were performed using a
visible platform raised 1 cm above the surface of the
water. Performance in the MWM was quantitated by
latency to find the platform.
Quantitation of traumatic lesion volume
Quantitation of traumatic lesion volume was performed
by following a standard method as previously described
[5]. At 3 weeks after TBI, mice were sacrificed and
transcardially perfused with chilled (4°C) PBS, pH7.4,
followed by 4% paraformaldehyde in 0.1 M PBS. Frozen
brains were sectioned with microtome into 20-μm-thick
coronal slices. Every 20th section was mounted onto a
glass slide and stained with hematoxylin and eosin.
Histological lesion areas were quantified with a standard
computer-assisted image analysis program (Image J), and
the lesion areas were then integrated to obtain total le-
sion volumes in cubic millimeters.
Statistical analysis
All data were expressed as mean ± SD. Sensorimotor
and MWM were analyzed by two-factor repeated-
measures analysis of variance (group×time). Slot-
immunobloting and western blot data were analyzed by
one-way ANOVA. Lesion volumes were analyzed by
t-test. For all comparisons, P<0.05 was considered
significant.
Results and discussion
Increasing evidence has demonstrated that Ngb plays an
important role in neuroprotection against hypoxic/
ischemic brain injury, such as stroke and other related
neurological disorders [5,19,20]. Our previous studies
showed that Ngb overexpression reduces tissue infarc-
tion and markers of oxidative stress in a focal stroke
mouse model [5]. Recent reports by others have shown
that Ngb gene expression was increased after TBI, but
its effects on outcomes were not examined [21,22]. In
this short study we tested our hypothesis that Ngb over-
expression may protect against traumatic brain injury in
mice. We performed three sets of experiments to exam-
ine (1) changes in brain Ngb protein expression after
TBI, (2) the effects of Ngb over-expression in a mechan-
istic endpoint-oxidative tissue damage, and (3) the
neurological outcomes of neurobehavioral deficits and
traumatic lesion size at three weeks after TBI. Both
Ngb-Tg and WT control mice were examined and
compared.
In the first set of experiments, we found that Ngb pro-
tein level in the injured brains were significantly
increased in both Ngb-Tg and WT mice compared to
their sham controls at 6 h after TBI. This examination
by immunohistochemistry (Figure 1A) and western blot
analysis (Figure 1B) was consistent with a report that
showed a transient increase of brain Ngb expression
with peak at 6 h after TBI in rats. That study also
showed Ngb over-expression decreased mechanical
injury-induced neuron death [23]. In our present study,
quantification of western blot analysis showed that the
basal levels of Ngb protein expression (149% of WT
sham control mice) and the CCI-induced increase of
Ngb protein levels at 6 h after TBI (196% of WT sham
control mice) were significantly higher in Ngb-Tg mouse
brains compared to WT TBI controls (147% of WT
sham control mice) (Figure1C). While this difference
suggested that TBI induces Ngb protein expression, the
basal and TBI-induced Ngb protein levels were still sig-
nificantly higher in Ngb-Tg mouse brains, validating the
possible causality between the different brain Ngb pro-
tein levels in association with different neurological out-
comes after TBI of Ngb-Tg and WT control mice.
Previous studies have demonstrated that Ngb over-
expression can reduce hypoxia/ischemia-induced oxida-
tive cell damage in cultured neurons and focal cerebral
ischemia in mice [5,19]. In the second set of experi-
ments, we tested and compared a common oxidative tis-
sue damage biomarker, 3NT production, in TBI-injured
brains of Ngb-Tg and WT control mice. We found that
there was a significant reduction of 3NT level at 6 h
after TBI in Ngb-Tg mouse brains as compared to WT
controls (Figure 2), indicating TBI-induced oxidative tis-
sue damage may be diminished by Ngb over-expression.
In the last set of experiments, we examined neuro-
logical outcomes of neurobehavioral deficits for up to
three weeks after TBI and traumatic brain lesion size at
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after TBI, sensorimotor functions were assessed by
neurological score and hanging wire tests. Body weight
loss was also measured on each test day. Experimental
data showed significant deficits in all tests from day 1 to
day 7 after TBI. All deficits were recovered close to pre-
injury baselines by day 21 after CCI. However, there
were no statistically significant differences between Ngb-
Tg and WT mice in all assessments during the 3-week
TBI recovery period (Table 1). We also used Morris
Water Maze to assess spatial memory acquisition at
15-21 days after TBI, but we did not find significant
differences between Ngb-Tg and WT mice in latency
for hidden and visible platform trials (Figure 3A), as
well as in probe trials (Figure 3B). Lastly, we quantita-
tively examined traumatic brain lesion volume and
found it was significantly reduced in Ngb-Tg mice
compared to WT mice at 21 days after TBI (Figure 4).
In the past two decades neuroprotectants that seek to
block or inhibit one specific step in the cascades of TBI
have not been very clinically successful [24]. It has been
shown that TBI triggers endogenous protective mechan-
isms that can prevent or limit brain damage. Methods
that seek to augment the brain's own endogenous pro-
tection and repair signals may lead to new therapeutic
strategies for stroke and related disorders [25]. Experi-
mental studies from our lab and others have documen-
ted that Ngb is one of very few unique molecules for
endogenous neuroprotection, which functions in stabil-
izing neuronal function and prosurvival genes under
both normal rest and hypoxic/ischemic conditions, serv-
ing to protect against oxidative stress and preserve mito-
chondrial function [4,9,26]. Furthermore, investigators
have recently been attempting to elucidate Ngb gene
regulation mechanisms, identifying small molecules that
can specifically up-regulate endogenous Ngb protein
expression for the development of novel endogenous
neuroprotection strategies for treating neurological dis-
orders [19,27]. Thus in this study, for the first time, we
tested whether Ngb overexpression has neuroprotective
effects in TBI model of mice. Results from present
work showed: (1) TBI significantly increased Ngb ex-
pression in peri-lesion of ipsilateral cortex at 6 h after
TBI compared to sham in both WT and Ngb-Tg mice,
but the increased Ngb level was significantly higher in
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Figure 2 Relative 3NT protein levels. Brian samples were
collected at 6 h postinjury in sham and TBI-injured WT and
Ngb-Tg mice. Slot-immunoblotting analysis was used to determine
relative 3NT protein levels. Data were expressed as mean ± SD.
*P<0.05, n=5 per group.
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Figure 1 Ngb expression levels in mouse brains after TBI. A.
Representative immunohistochemistry of Ngb protein expression in
WT and Ngb-Tg mice cortex of peri-lesion area at sham animals and
at 6 h after TBI. Original magnification×200 in all photomicrographs.
B. Representative western blot of Ngb protein expression in WT and
Ngb-Tg mice cortex of peri-lesion area at sham animals and at
6 h after TBI, β-actin served as equal protein loading controls.
C. Quantitation of Ngb protein levels. Data were expressed as
mean ± SD. *P<0.05, n=5 per group.
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http://www.biomedcentral.com/1471-2202/13/67Ngb-Tg mice than WT controls; (2) Ngb-Tg significantly
reduced the levels of oxidative damage marker 3NTat 6 h
after TBI in Ngb-Tg mice compared to WT controls;
(3) Ngb-Tg mice exhibited smaller lesion volumes at
3 weeks after TBI compared to WT; (4) however, there
were no significant differences in neurobehavioral deficits
between the WT and Ngb-Tg mice after TBI for up to
three weeks.
Ngb-Tg mice exhibited smaller cortical lesion volumes,
suggesting that Ngb overexpression may prevent TBI-
induced brain tissue damage. Oxidative stress has a
mechanistic role in the pathophysiology of many neuro-
logic diseases, including traumatic brain injury [15], and
previous studies have shown that Ngb over-expression
may reduce hypoxia/ischemia-induced oxidative stress
in cultured neurons and a focal stroke mouse model
[4,5,9]. Additionally, 3NT production at early time
points after brain injury is associated with the degrees
of TBI-induced oxidative tissue damage [15,28,29].
Thus, we tested and compared 3-NT production levels
in the brain tissues of Ngb-Tg mice and WT mice after
TBI. The significant reduction of 3-NT production in
Ngb-Tg mouse brains suggested that Ngb over-expression
may protect TBI brain damage, at least partially, by de-
creasing oxidative stress, which has been similarly
observed in other studies of cells cultures and animal dis-
ease models [5,9,19]. Although we did know exactly why
there was no effects of Ngb-Tg in oxidative stress reduc-
tion in the sham mice, but we may speculate that Ngb
may have multiple functions for cell protection by main-
taining hemostasis via stress sensing, or transducing
signals or direct action. Ngb might respond stress to
eliminate excessively elevated oxidative signaling and
tissue damage, but is not or less effectively taking ac-
tion under physiological resting conditions [4,8-11].
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Figure 3 Spatial memory acquisitions in WT and Ngb-Tg mice
after TBI. A. Morris water maze latencies were measured on days
15-21 for hidden and visible platform trials after TBI. B. Morris water
maze latencies were measured on days 15-21 for probe trials after
TBI. Data were expressed as mean ± SD. n=15 for WT and 11 for
Ngb-Tg per group, respectively.
Table 1 Sensorimotor Function Assessments
Tests Neurological score median
(25th to 75th percentiles)
Hanging wire median
(25th to 75th percentiles)
Body Weight,
% of day 0
Group WT Ngb-Tg WT Ngb-Tg WT Ngb-Tg
Day 0 0 0 5.0 (4.8-5.0) 4.7 (4.9-5.0) 100 100
Day 1 3.0 (2.0-3.5) 5.0 (3.0-6.0) 3.0 (2.2-3.7) 3.0 (2.0-3.3) 97.2±6.67 95.5±3.74
Day 3 2.0 (1.0-2.5) 2.0 (1.0-3.5) 4.0 (2.7-4.3) 2.7 (2.2-4.2) 100.1±6.02 97.5±2.18
Day 5 1.0 (1.0-2.0) 2.0 (1.0-2.0) 4.0 (3.3-4.7) 4.0 (3.2-4.3) 99.7±6.81 98.5±2.94
Day 7 1.0 (1.0-2.0) 1.0 (1.0-1.0) 4.3 (4.2-4.7) 4.0 (3.2-4.1) 103.8±6.96 97.8±4.09
Day 10 1.0 (1.0-2.0) 0.0 (0.0-1.0) 4.3 (4.0-4.8) 4.0 (4.0-4.0) 103.8±6.96 97.8±4.09
Day 14 1.0 (1.0-1.0) 0.0 (0.0-1.0) 4.3 (4.0-4.8) 4.0 (3.8-4.0) 105.1±6.74 99.4±4.32
Day 21 1.0 (0.0-1.0) 1.0 (0.0-1.0) 4.3 (4.1-5.0) 4.0 (3.8-4.0) 108.3±7.48 109.5±4.36
Sensorimotor deficits and body weight loss were assessed before (day 0) and at days 1, 3, 5, 7, 10, 14, 21 after CCI. Results are expressed as median values and
25
th to 75
th percentiles for assessments of neurological score, hanging wire tests; and mean ± SD for assessments of body weight loss. N=11 for Ngb-Tg and 15
for WT per group. In all assessments, there were no statistical significant differences between WT and Ngb-Tg groups.
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not significantly altered as observed in present work.
We acknowledge that the early reduction of 3NT pro-
duction at 6 hours after TBI in Ngb-Tg mice might be
correlated with the lesion reduction at 3 weeks, but
other factors likely also contribute to the neuroprotec-
tion of Ngb-Tg in TBI. A number of laboratories, includ-
ing ours, have demonstrated that Ngb is protective
against hypoxic/ischemic brain injury. Although the
underlying mechanisms remain poorly defined, initial
evidence suggests that the neuroprotective effect of Ngb
may be linked largely to the structural features related to
O2 and NO binding. Furthermore, putative signal trans-
duction and mitochondrial function preservation also
may be involved in the protective mechanisms [4,8-11].
However the involved molecular mechanisms need to be
investigated in further studies.
It is worthy of noting that, there are two published
studies closely related to the present work. A recent
study showed that over-expression of Ngb in cultured
neurons was neuroprotective against mechanical injury
in vitro. This study also showed increased Ngb expres-
sion levels with peak time of 6 hours after TBI, and
these increased levels correlated to the severity of TBI in
rats [23]. Thus, we picked only the time point of 6 hours
after TBI for examining changes of Ngb expression and
3NT production after TBI in present study. One of our
previous studies in focal stroke showed oxidative tissue
damage biomarker malondialdehyde levels in ischemic
hemispheres of Ngb-Tg were significantly reduced com-
pared with wild-type controls at 8 hours and 22 hours
after transient focal cerebral ischemia. Brain infarction
volumes 1 day and 14 days after stroke were significantly
reduced in Ngb-Tg mice. However, there were no signifi-
cant detectable improvements in sensorimotor deficits
for up to 14 days after stroke in Ngb-Tg mice compared
with wild-type controls [5], which was similarly observed
in present work in TBI mice.
We are aware that there are a few limitations in this
study. First, the total Ngb protein expression levels in
our Ngb-Tg mouse line is about 1.5 fold of WT control,
which is relatively lower than when the Ngb-Tg mouse
line was newly generated 5 years ago [5]. The decline of
the Ngb protein level in Ngb-Tg mice may be mainly
due to the endogenous depletion of inserted exogenous
DNA fragments or inactivation of its promoter [30,31].
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Figure 4 Measurements of cortical lesion volume in WT and Ngb-Tg mice. A. Representative photomicrographs of the traumatic lesions in
H&E stained WT and Ngb-Tg mouse brain sections at 21 days after TBI. B. Traumatic brain lesion size. Data were expressed as mean ± SD.
*P<0.05, n=15 for WT and 11 for Ngb-Tg per group, respectively.
Zhao et al. BMC Neuroscience 2012, 13:67 Page 6 of 8
http://www.biomedcentral.com/1471-2202/13/67However findings from present work are still very in-
formative and suggest that Ngb over-expression might
be a new target for TBI therapy strategy development.
We are working on a generation of neuron-specific and
inducible Ngb-Tg mouse line for future studies of Ngb
over-expression effects in TBI neurological outcomes
and underlying molecular mechanisms. The second limi-
tation is related to mechanisms. We only detected the
reduction of 3-NT production in the Ngb-Tg mouse
brains at the early time of 6 hours after TBI, suggesting
there might be an antioxidative role for Ngb in vivo.
However, for in vivo TBI models, it is difficult to un-
equivocally prove causality because reduced tissue dam-
age may secondarily contribute to decreased oxidative
stress and/or mitochondrial dysfunction. The third limi-
tation is that we failed to detect significant differences in
sensorimotor function or spatial memory function re-
covery between WT and Ngb-Tg mice. In part, this is be-
cause the TBI setting in our study might not be severe
enough to cause long-term sensorimotor deficits since
most of the deficits recovered close to the pre-injury
baseline from one to two weeks after TBI. Also, the Ngb
protein level in Ngb-Tg mouse brain might not be high
enough. Alternatively, we may have simply lacked power
and larger numbers of test animals would have helped.
Further investigation is warranted to carefully define the
role of Ngb in both long-term sensorimotor and cogni-
tive deficits after TBI.
Conclusions
These experimental results suggest that Ngb over-
expression can reduce traumatic brain lesion volume,
possibly through reduction of oxidative stress.
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